Skip to main content

Vivek Rakolia

Analyst

FICOM Family Office

Equibles does not estimate personal net worth.

About Vivek Rakolia

Vivek Rakolia is recorded as Analyst at FICOM Family Office. Vivek Rakolia has spoken on 3 earnings calls across 3 companies, most recently for Privi Speciality Chemicals Limited on July 31, 2026. Those appearances were for Privi Speciality Chemicals Limited, HLE Glascoat Limited and Anthem Biosciences Limited. The companies whose calls Vivek Rakolia spoke on are classified in the Basic Materials, Industrials and Healthcare sectors.

Vivek Rakolia on recent calls

“So, gross margin came in at 44.2% in Q1, FI27 versus almost 51% in last year Q1, FI26, which is a decline of about 650 basis points, even as the revenue grew by 20%.”
Analyst — FICOM Family Office, Earnings Call for the Quarter Ended June 30, 2026 ·
“The first question was, in the Q2 call, the management had expected an EBITDA margin of 16% for the full year of FI26. The actual stood at 11%.”
Analyst — FICOM Family Office, Earnings Call for the Quarter Ended March 31, 2026 ·
“I wanted to understand firstly, on the peptide front, A listed peer claims to have also developed the capability of making the full peptide chain, right, from fragments to the APIs.”
Analyst — FICOM Family Office, Anthem Biosciences Limited Q4 & FY26 Earnings Conference Call ·

Affiliation history

  • FICOM Family Office

    Analyst

    Transcript header (unverified)

    Current

Company network

Privi Speciality Chemicals Limited

Specialty Chemicals · Basic Materials

1 appearance Latest appearance 2026-07-31

HLE Glascoat Limited

Specialty Industrial Machinery · Industrials

1 appearance Latest appearance 2026-05-25

Anthem Biosciences Limited

Biotechnology · Healthcare

1 appearance Latest appearance 2026-05-20

Recent activity

  • Earnings call

    Earnings Call for the Quarter Ended June 30, 2026

    Privi Speciality Chemicals Limited

  • Earnings call

    Earnings Call for the Quarter Ended March 31, 2026

    HLE Glascoat Limited

  • Earnings call

    Anthem Biosciences Limited Q4 & FY26 Earnings Conference Call

    Anthem Biosciences Limited